Rubella virus (RUBV) contains a plus-strand RNA genome with two ORFs, one encoding the nonstructural replicase proteins (NS-ORF) and the second encoding the virion structural proteins (SP-ORF). This study describes development and use of a trans-encapsidation system for the assembly of infectious RUBV-like replicon particles (VRPs) containing RUBV replicons (self replicating genomes with the SP-ORF replaced with a reporter gene). First, this system was used to map signals within the RUBV genome that mediate packaging of viral RNA. Mutations within a proposed packaging signal did not significantly affect relative packaging efficiency. The insertion of various fragments derived from the RUBV genome into Sindbis virus replicons revealed that there are several regions within the RUBV genome capable of enhancing encapsidation of heterologous replicon RNAs. Secondly, the trans-encapsidation system was used to analyse the effect of alterations within the capsid protein (CP) on release of VRPs and subsequent initiation of replication in newly infected cells. Deletion of the N-terminal eight amino acids of the CP reduced VRP titre significantly, which could be partially complemented by native CP provided in trans, indicating that this mutation affected an entry or post-entry event in the replication cycle. To test this hypothesis, the trans-encapsidation system was used to demonstrate the rescue of a lethal deletion within P150, one of the virus replicase proteins, by CP contained within the virus particle. This novel finding substantiated the functional role of CP in early post-entry replication.
INTRODUCTION

Rubella virus (RUBV) is the only member of the genus
Rubivirus of the family Togaviridae. RUBV causes a mild disease in children and adults, but operates as an extremely efficient teratogen when fetal infection occurs. The enveloped virus particle contains a positive-sense ssRNA genome contained in a quasi-spherical capsid composed of the virus capsid protein (CP) and the envelope contains spikes composed of two envelope glycoproteins, E2 and E1. The viral genome contains two non-overlapping ORFs. The 59-terminal ORF (NS-ORF) encodes the non-structural replicase proteins P150 and P90 and is translated from the genomic RNA as a polyprotein in the order NH 2 -P150-P90-COOH. The 39-terminal ORF (SP-ORF) encodes the structural proteins and is translated from a subgenomic (sg) RNA as a polyprotein in the order NH 2 -CP-E2-E1-COOH (Frey, 1994) .
Following uptake and entry, RUBV replication complexes, the sites of virus RNA synthesis, form vesicles which internally line converted cytoplasmic vacuoles that are reported to be of endosomal/lysosomal origin (Magliano et al., 1998) . Initial translation of the non-structural proteins into a P200 polyprotein directs negative-strand RNA in a cis-preferential manner. P200 is proteolytically processed into P150 and P90 that act together as the positive-strand RNA replicase (Liang & Gillam, 2001) . RUBV replication complexes are closely associated with the ER, mitochondria and Golgi stacks, the latter site being where virus assembly occurs (Risco et al., 2003) . Encapsidation of the RUBV genome was reported to be mediated by a CP proteinbinding site between nt 347 and 375 in the viral genome and a RNA-binding domain on CP comprising aa 28-56 (Liu et al., 1996) .
Besides its structural roles in encapsidation of the genome and virion assembly, several non-structural functions have been assigned to the CP such as regulating the amount of genomic RNA relative to sgRNA (Tzeng & Frey, 2005) and rescuing a large, lethal deletion in the P150 replicase protein (Tzeng & Frey, 2003; . Phosphorylation of serine 46 within CP negatively regulates RNA binding of CP (Law et al., 2003) and influences the rate of RNA replication (Law et al., 2006) . CP also interacts with the mitochondrial matrix protein p32 (Beatch & Hobman, 2000) , triggering mitochondrial redistribution in RUBV-infected cells, blocking mitochondrial transport and inhibiting apoptosis (Beatch et al., 2005; Ilkow et al., 2010 Ilkow et al., , 2011 .
The RUBV structural proteins assemble into RUBV-like particles (RLPs) in a genome-independent manner when the structural protein ORF is expressed by itself in cells Qiu et al., 1994) . RLPs are very similar to RUBV virions in their size and morphology enabling their use as a model system to study RUBV morphogenesis (Garbutt et al., 1999a, b; Lee et al., 1996; Yao & Gillam, 2000) . In this report, we developed a replicon trans-encapsidation system by transfecting a packaging cell line expressing the RUBV structural protein ORF with in vitro RNA transcripts of replicons. Replicons are cDNA constructs in which the structural protein ORF has been replaced with a reporter gene and thus are capable of replicating in transfected cells, but lack the means for cell-to-cell spread or virion formation because they do not encode the structural proteins (Tzeng et al., 2001) . Replicons are efficiently packaged with this trans-encapsidation system achieving secretion of single-round infectious RUBV-like replicon particles (VRPs) at titres comparable to RUBV. We used the trans-encapsidation system to analyse (i) encapsidation signals within RUBV genome, (ii) the effect of alterations within the CP on RNA encapsidation and particle entry and (iii) the participation of CP in the virus particle in early post-entry replication.
RESULTS
Trans-encapsidation system
The trans-encapsidation system employed consisted of a BHK cell line stably expressing the RUBV structural proteins, BHK/CE2E1, which was transfected with in vitro replicon RNA transcripts. While the assembly of RLPs was initially described in a CHO line stably expressing the RUBV structural proteins (CHO24S) , we found that the titre of packaged replicons was higher in the BHK/CE2E1 cells (data not shown). Using the BHK/CE2E1 cells, titres of VRPs containing one of three versions of RUBV replicons used in other studies (Tzeng & Frey, 2003 Tzeng et al., 2001 ) each expressing the GFP reporter gene (RUBrep/GFP, RUBrep/C-GFP and RUBrep/C-GFP-E1; see Fig. 1a) were similar, i.e.~10 6 infectious GFP transducing units (GTU) ml 21 .
Mapping putative RUBV packaging signals (PSs)
RUBrep/C-GFP-E1, a replicon derived from a naturally selected defective-interfering (DI) RNA that encodes a fusion protein consisting of the N-terminal part of CP, GFP and the C-terminal part of E1 was used to analyse the PS proposed by Liu et al. (1996) between nt 347 and 375 of the RUBV genome. Mutagenesis using degenerate primers was applied to introduce synonymous third codon mutations into this region as deletion of the entire region abrogated replicon replication (data not shown). Fig. 1(a) summarizes the panel of eight mutations that were generated, each of which changed 8 or 9 of the 30 nt contained within the putative PS. Also shown in Fig. 1 are micrographs showing the GFP signal (from the C-GFP-E1 fusion protein) (Fig. 1a) and a Northern blot showing RNA synthesis following transfection of Vero cells with these mutant constructs (Fig. 1c) . Of this mutant panel, only one (mutant 5) produced a GFP signal approaching that produced by the parent non-mutant replicon and detectable RNA, indicating impairment of replication by most of the mutants. We previously reported that synonymous mutations in this region of the genome could dramatically alter replication (Pugachev et al., 2000) . The titres of VRPs containing one of eight mutant replicons are shown in Fig. 1(b) . With one exception, the packaging efficiency of the PS mutants was roughly 1 log or more lower than the non-mutant parent replicon and thus corresponded to the relative reduced level of replication of these replicons as detected by GFP expression and RNA synthesis. The exception, modPS-5, exhibited both a replication and packaging efficiency approaching the non-mutant parent replicon. If nt 347-375 were the PS, it would be expected that packaging efficiency would be uncoupled from replication efficiency in that some of the mutants would exhibit no packaging, particularly considering the number of mutations introduced into the putative PS. Thus, these results do not support the notion that the PS resides exclusively in this short segment of the RUBV genome.
To screen the remainder of the RUBV genome for potential PSs, Sindbis virus (SINV) replicons (SINrep) that are inefficiently packaged by the BHK/CE2E1 packaging cell line were employed as carriers for accommodating longer stretches of the RUBV genomic sequence (Fig. 2b) . In our search for RUBV PSs, we concentrated on the NS-ORF as DI RNAs lacking most of or the entire SP-ORF are efficiently maintained during serial passage in culture (Derdeyn & Frey, 1995; Frey & Hemphill, 1988 ) and replicons such as RUBrep/GFP lacking the SP-ORF are efficiently packaged (Fig. 1b) . The NS-ORF including the 59 UTR was divided into six segments of about 700-1200 nt (Fig. 2a) . Additionally, two~200 bp fragments comprising nt 320-514 and 488-691, which either contained or lay downstream of the PS between nt 347 and 375 proposed by Liu et al. (1996) , were used to further evaluate this putative PS. While some of these fragments, including the 200 bp fragments, were inserted in either orientation into a StuI site within the 39 UTR of the SINrep RNA, the complete NS-ORF scan was also inserted into an XbaI site upstream of the reporter GFP gene, which created an inframe fusion (Fig. 2a) . Fig. 2(b) compares the relative packaging efficiency of this collection of replicons. The insertion of the neighbouring 200 bp fragment lacking or comprising the putative PS in either orientation failed to increase packaging above the background level. However, the insertion of the first~1000 nt of the RUBV genome, in either orientation, at the StuI site increased packaging about 15-20-fold and a similar packaging enhancement was found when this fragment was placed in the XbaI site.
From among the remainder of the NS-ORF-scanning fragments, all except nt 926-1669 enhanced encapsidation between~20-and 50-fold with the highest packing efficiency bestowed by insertion of nt 3986-5284.
--
Fig. 1. Trans-encapsidation system; replicon constructs, mutagenesis of the putative PS and packaging efficiencies. (a) At the top are shown diagrams of the RUBV genome (with nucleotide coordinates of the NS-ORF given) and a naturally occurring DI-RNA below; also shown are three replicon constructs with a GFP reporter gene expressed from the sgRNA that were used in this study. Third codon mutagenesis employing a degenerate primer was used to produce eight mutations in the putative PS between nt 347 and 374 in RUBrep/C-GFP-E1 ( The complete blot is shown at the bottom with the migration of the gRNA, sgRNA and 18S rRNA (which co-migrates with the sgRNA of these constructs, causing an artefactual band in lanes with constructs with minimal or undetectable RNA accumulation, i.e. other than the wt and modPS5 replicons). Above the complete blot is the portion of the blot containing the gRNA exposed for twice as long.
Insertion of the RUBV C gene in the SINrep in-frame with GFP failed to increase titre, validating our decision to concentrate on the NSP-ORF. In summary, using our trans-encapsidation system for packaging of RUBV VRPs and SINrep, we were not able to identify a specific RUBV PS, including the previously reported PS, and instead it appears that several longer stretches of the RUBV genomic RNA can enhance packaging.
Effect of alterations of CP on packaging
BHK/CE2E1 cell lines expressing wt or mutant CPs were used to assess the effect of these mutations on packaging.
In particular, there is a pair of in-frame AUGs separated by seven codons at the beginning of the CP gene and it has been speculated that both may be employed considering that the downstream AUG is in a better Kozak context for initiation of translation (Frey, 1994) . Therefore, a BHK/ CE2E1 cell line expressing a CP with a deletion of the first AUG and the next seven codons (CD8) was generated. Following transfection of both cell lines with RUBrep-GFP transcripts, the titre of infectious VRPs produced (as assayed on Vero cells) was almost 2 logs higher from the wild-type (wt) cells than from the CD8 mutant cells (Fig.  3) , suggesting that the N terminus of the CP initiating from the first AUG was necessary for packaging. Intriguingly, however, when assayed on C-Vero cells, a cell line expressing CP (aa 1-277, lacking the E2 signal sequence) , the infectious VRP titre from the CD8 cells was~fivefold higher, while there was no difference in the infectious VRP titre from the wt cells between Vero and C-Vero cells. C-Vero cells have been shown to potentiate replication of transfected replicon transcripts and therefore we considered the possibility that VRPs were released efficiently from the CD8 cell line, but the CP protein lacking the first eight amino acids was not able to participate in early post-entry steps in virus replication. Consistent with this line of thinking, we showed previously that CP was able to rescue internal deletions in the P150 gene at an early step in replication, whereas the CP with the D8 deletion was not . Therefore, to determine whether there was any difference in the amount of physical RLPs released from BHK/CE2E1 and BHK/CD8E2E1 cells, both cell lines were radiolabelled and the amount of virus protein in both the cell lysate and the cell medium was determined. As shown in Fig. 4 , there was somewhat more CP present in the BHK/ CD8E2E1 lysate than in the BHK/CE2E1 lysate but equal amounts of E2 and E1 (for unknown reasons) and it appeared that more RLPs were released from BHK/ CD8E2E1 cells than from BHK/CE2E1 cells. Thus, the CD8 mutation does not adversely alter the release of RLPs, consistent with the notion that CP in the virus particle plays a role in an early post-entry replication event and that the mutant CP lacking the N-terminal amino acid is deficient in this event. Based on these results, to determine if CP in the virus particle plays a role in early post-entry events, the subsequent experiments were undertaken.
Analysis of involvement in early post-entry replication by CP in virus particles
Expression of the GFP reporter protein encoded by RUB replicons can be initiated either by transfection of cells with replicon transcripts or infection with infectious VRPs containing replicons. As shown in To confirm a function in early post-entry replication played by CP in the virus particle, the following strategy was employed. It has been shown that a large (500 bp), lethal, in-frame deletion between two NotI sites in the P150 gene can be rescued by CP and that this rescue occurs at an early stage in replication because in the absence of CP no RNA accumulation in cells transfected with replicons bearing the NotI deletion is detected (Tzeng & Frey, 2003) . A dual reporter replicon, (RUBrep/GFP-RFP) was constructed in which GFP was inserted in the downstream NotI site of P150 and the red fluorescent protein (RFP) was expressed from the sgRNA and used as the reporter protein.
The insertion of the GFP sequence into the P150 coding region abolishes replication, except in the presence of CP, and thus abrogates RFP expression from the sgRNA. As shown in Fig. 6 , transfection of transcripts of this construct into Vero and C-Vero cells resulted in expression of GFP-tagged-P150 (due to translation of the transfected transcripts) at 1 day post-transfection in both cell lines. However, only in C-Vero cells was amplified expression of GFP-tagged-P150 and of RFP expression visible at 2 days post-transfection. VRPs with packaged RUBrep/GFP-RFP replicons were prepared in BHK/CE2E1 cells (the C expressed in these cells allows the replicon to replicate). As shown in Fig. 6 , unlike the results following transfection, amplified GFP expression and RFP expression were detectable 2 days post-infection with the VRPs containing RUBrep/GFP-RFP replicons in both Vero and C-Vero cells. Since the only source of CP in the infected Vero cells is from the infecting VRPs, this result proves that CP in the virus particle plays a function (i.e. the NotI rescue function) in early post-entry replication.
DISCUSSION
Trans-packaging/encapsidation systems have been developed for a number of virus families. In the case of the alphaviruses, the other genus of the family Togaviridae, efficient trans-encapsidation systems have been put to use both to gain knowledge about virus functions, but also to develop transport/entry vehicles and single cycle vaccine vectors (Atkins et al., 2008; Lundstrom, 2002; Schlesinger, 2001 ).
Interestingly, alphavirus particles fail to form unless an appropriate nucleating nucleic acid is present. In contrast, rubella-like particles or RLPs were shown to be formed by the RUBV virion proteins without detectable RNA Qiu et al., 1994) and have been used to study protein function [e.g. that dimerization of the CP is not necessary for particle formation (Lee et al., 1996) ], as prototype inactivated vaccines and for immunological assays (Giessauf et al., 2005; Grangeot-Keros & Enders, 1997; Pustowoit et al., 1996) . In this study, we showed for the first time that RUBV replicons could be efficiently packaged into VRPs. Relying on GFP expression by the packaged replicons, we were able to quantify packaging efficiency.
We first used the trans-encapsidation system to study PSs within the RUBV genome, which would be the first step toward developing a trans-encapsidation system that would package heterologous RNAs. A putative PS had been predicted based on an in vitro RNA/CP-binding assay (Liu et al., 1996) and we approached ascertaining its functionality by making multiple synonymous third codon position changes within it. We encountered a propensity of the majority of these mutations to hinder virus replication, indicating that either codon usage or secondary structure is important for RNA replication. We had previously reported synonymous codon changes at nt 164-165 of the RA27/3 vaccine strain that resulted in attenuation of replication efficiency of the resulting virus (Pugachev et al., 2000) . However, packaging efficiency of these mutated replicons correlated with replication efficiency and none of them abrogated packaging, strongly suggesting that this sequence was not a functional PS. Packaging of heterologous SINrep RNAs containing fragments from the RUBV NS-ORF was then employed with the outcome that the majority of longer (.1000 nt) fragments increased the packaging efficiency, suggesting that encapsidation of RUBV genomic RNA is the result of binding of CP to longer stretches of the genomic RNA rather than binding to a specific short PS. However, inclusion of the CP gene in the SINrep did not increase packaging efficiency, indicating a modicum of specificity that would prevent packaging of the sgRNA.
There are several examples listed in the literature about viruses with known PSs such as the infectious bronchitis virus PS within the 59 and 39 UTRs (Dalton et al., 2001) , the hepatitis B virus (HBV) 85 nt PS (Bartenschlager et al., 1990) and the human immunodeficiency type 1 virus (HIV-1) PS within the leader region (Clever et al., 2002) . The PSs in several alphaviruses have been identified (Frolova et al., 1997; Kim et al., 2011) . Unlike the previous cited examples, alphavirus PSs are hundreds of nucleotides in length, contain a secondary structure consisting of a series of stems with GGG loops, occur in different regions of the nonstructural ORF in different viruses, and are recognized heterologously by the CPs of different viruses despite the fact that they share little homology at the nucleotide level (Kim et al., 2011) . However, encapsidation is not always entirely based on recognition of a specific PS. HBV genome encapsidation involves a ribonucleoprotein complex besides recognition of a specific PS by the CP (Bartenschlager et al., 1990; Chen et al., 1992; Pollack & Ganem, 1994) . In poliovirus-infected cells RNA packaging and replication seem to be connected through colocalization of RNA replication complexes and virion precursors (Nugent et al., 1999) . Data presented in this study suggest that encapsidation of RUBV RNA is based on CP binding to long stretches of RNA. The RUBV genomic RNA is GC rich (70 %) and thus recognition may be based on extensive, stable secondary structure. It is also possible that encapsidation is in association with RNA synthesis within RUBV replication complexes as areas of RUBV replication and assembly seem to be physically connected based on the detection of Golgi stacks, the site of RUBV assembly, close to cytopathic vacuoles containing replication complexes (Risco et al., 2003) . However, the ability of RUBV structural proteins to encapsidate heterologous SINrep RNA indicates that packaging is not entirely dependent upon the proximity of RUBV replication complexes.
The second use we made of the trans-encapsidation system was to study the effect of mutations in the CP on packaging. Specifically, we examined the deletion of the N-terminal AUG and the following seven amino acids in the C gene, forcing production of a protein starting at the second AUG within the gene, which happens to be in a better Kozak context for initiation of translation than does the first AUG. This deletion led to a 100-fold reduction in VRP titre, indicating that the full-length protein initiated at the first AUG is necessary for encapsidation. Interestingly, however, the titre exhibited by VRPs containing this mutation could be increased by CP provided in trans in the target cells. Subsequently, it was found that the deletion had no effect on release of particles from producer cells. Taken together, these results suggested that the defect in part exhibited by the CD8 mutant involved early replication in the target cells, indicating a specific role for CP in the infecting virus particle. We have shown previously that CP expressed in cells can participate in the early stages of RNA replication, specifically through its ability to rescue a large deletion between two in-frame NotI sites in the P150 gene and, significantly, CP with the CD8 mutation is deficient in this rescue function . To test the hypothesis that CP in the virus particle plays a role in the early stages of virus RNA replication, we used the transencapsidation system to package replicons with a lethal insertion of GFP in the NotI region of the P150 gene. These packaged mutant replicons were able to replicate in Vero cells, proving the hypothesis.
The mechanism through which CP participates in early RNA replication is under intensive investigation in our lab (Tzeng & Frey, 2003 . In addition to rescue of P150 deletions, CP also rescues lethal mutations in both the 59 and 39 cis-acting elements in the genome RNA . The amount of CP incoming with the virus particle is limited and to explain rescue of this diverse set of mutations by limited copies of a protein, we propose the model that both the CP and NotI region of P150 serve as RNA chaperones. We showed recently that CP could replace the NotI region of P150 in replicons with maintenance of viability and thus the two share a redundant function (Tzeng & Frey, 2009) . A chaperone activity within CP would also explain the potentiation of wt replicon replication in transfected CVero cells. In this model, in the normal infection process CP in the virus particle plays the chaperone role until the NotI domain of P150 is translated and matures. Examples of viral capsid or core proteins that function as RNA chaperones include the nucleocapsid protein of HIV-1 (Cruceanu et al., 2006) , the core protein of hepatitis C virus (Cristofari et al., 2004) and the bunyavirus N protein (Mir & Panganiban, 2006) . We are not aware of other animal virus capsid or core proteins serving this role as members of the infecting virus particle. The nucleocapsid proteins of negative-polarity RNA viruses function structurally in the RNA-dependent-RNA polymerase complex after infection and it was recently shown that mutations in the capsid protein of incoming virions of the tick-borne encephalitis and West Nile virus adversely affected uncoating and/or early viral RNA synthesis (Schrauf et al., 2009) . The only corresponding example in a positivesense RNA virus of the capsid/core protein playing an early post-entry role in virus replication is the ilarvirus (e.g. alfalfa mosaic virus) capsid protein which is involved in genome activation and initiation of infection that requires its binding to specific sites on the incoming genomic RNA (Bol, 1999; Guogas et al., 2005; Swanson et al., 1998) 
METHODS
Cell lines. Vero (ATCC CCL-81) and BHK21 (baby hamster kidney; ATCC CCC-10) cells were propagated in Dulbecco's modified Eagle's medium (DMEM; Gibco) with 5 % FBS and 10 mg gentamicin ml 21 at 35 uC in a 5% CO 2 /95 % air atmosphere. C-Vero, which constitutively express residues 1-277 of the RUBV CP (lacking the C-terminal E2 signal sequence) , were cultured similarly except that the medium contained 400 mg G418 ml
21
.
Generation of constructs. The following constructs were described previously: RUBV infectious cDNA clone Robo502 (Tzeng & Frey, 2003) , the RUBV replicons RUBrep/GFP, RUBrep/C-GFP and RUBrep/C-GFP-E1 (Tzeng & Frey, 2003 Tzeng et al., 2001) . The RUBrep/C-GFP-E1 is based on a DI RNA species .
Construction of modPS mutants plus RUBrep-GFP-RFP.
To create the PS with synonymous third codon position mutations inserted between nt 347 and 375 of the genome, a three-round asymmetrical PCR amplification strategy (Tzeng & Frey, 2003) was employed with a first round mutagenic primer with the sequence 59-GGCCTGCTCCGCGAGGTDGCVCGDGTVGAACGDCGDTGGGT-DGCVCGDGTVGAACGDCGDTGGGTDGCBCTGTGCCTCCACA-GCVCGDGTVGAACGDCGDTGGGTDGCBCTGTGCCTCCACAG-G-39. The non-cytopathic SINrep has been described previously (Agapov et al., 1998; Pappas et al., 2006) . PCR amplification was used for the cloning of fragments from the RUBV genome into SINrep at either the XbaI site at the 59 end of the GFP gene (creating an inframe fusion protein) or the StuI site in the 39 UTR. EcoRI linearized Robo502 was used as templates and upstream, and downstream oligonucleotides contained nucleotides at either end of the fragment to be amplified plus suitable restriction enzyme sites for introduction into the SINrep vector (the upstream primer used to amplify fragments for introduction into the XbaI site also contained an ATG to allow for translation of the GFP fusion protein).
Transfection and clonal selection of stable cell lines. DNAmediated transfections were carried out using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. The BHK21 cell line was cotransfected with pTK-Hygro (Clontech) containing hygromycin resistance gene and pcDNA3.1 (Invitrogen) expressing the SP-ORF (CE2E1) or the SP-ORF containing a CP truncated by eight amino acids at its N terminus (CD8E2E1). Cotransfection was followed by hygromycin selection (Invitrogen) at a concentration of 300 mg ml 21 and maintenance at a concentration of 100 mg ml 21 . Single cells were picked, subcultured and selected for their level of protein expression by Western blot analysis. Stable cell lines were named according to the expressed protein(s). CHO24S cells were kindly provided by Tom Hobman (University of Alberta).
Preparation of RUBV VRPs and determination of their titre. For packaging in the BHK21 stable packaging cell lines, 3610 5 cells were plated in 35 mm dishes and transfected 48 h after seeding with the respective replicon transcript (prepared as described previously; . Supernatants were collected 48 h post-transfection, clarified by both centrifugation for 10 min at 1500 g and filtration through 0.45 mm-pore-size membranes (Nalgene). VRP titres were determined in Vero cells or C-Vero cells plated in 35 mm dishes (3610 5 cells per dish) 24 h before infection. Cells were infected with 10-fold serial dilutions of VRP stocks made in DMEM with 2 % FBS and incubated at 35 uC for 48 h. VRP titre was determined by calculating the number of GFP-expressing cells in the end-point dilution. Titres were expressed as GTU ml 21 cell culture supernatant.
Analysis of transfected and infected cells. For microscopic analysis of living cells that were transfected or infected with VRPs containing packaged replicons, low magnification fluorescence microscopy (610 or 620 objective) was used to directly examine cells without fixation. All cells were analysed using an Axioplan 2 microscope (Zeiss) with epifluorescence capacity. Post-acquisition processing of digital images was performed with Adobe Photoshop 5.5 software with minimal alterations to contrast and background. For detection of replicon RNA synthesis, transfected cells were lysed 3 days post-transfection and analysed by Northern blot using a 32 Plabelled nick translated GFP gene probe as described previously .
Immunoprecipitation. The protocols for immunoprecipitation have been described previously . Monolayers of BHK/ CE2E1 and BHK/CD8E2E1 cells were 35 S-methionine labelled for 24 h and after removal of the supernatant, the cells were lysed. Proportional aliquots of both lysates and supernatant was incubated with mAbs against C, E2 and E1 proteins (Viral Antigens Inc.). The immunoprecipitated proteins were resolved by SDS-PAGE, followed by drying of the gel and exposure to X-ray film.
